5 years ago
MRNA
AnalystsEmmanuel PapadakisEmmanuel Papadakis's Stock Forecasts
AnalystsEmmanuel Papadakis
Analyst Ranking
Bottom 16%
#4658 out of 5510 analysts
Average Return
-1.95%
Win Rate
40%6 out of 15
Risk vs Reward
Poor
Good
Emmanuel Papadakis's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Biontech SeBNTX | +40.44% | $79.25 | $111.30 | 2024-08-07 - 2025-08-06 | Strong Buy |
Novo Nordisk A SNVO | +33.72% | $36.02 | $48.16 | 2021-01-15 - 2022-01-14 | Strong Buy |
Novo Nordisk A SNVO | +30.73% | $53.12 | $69.45 | 2022-03-16 - 2023-03-16 | Strong Buy |
Astrazeneca PLCAZN | +14.63% | $102.68 | $117.70 | 2021-01-15 - 2022-01-14 | Strong Buy |
Novartis AgNVS | +2.50% | $82.80 | $80.73 | 2021-09-20 - 2022-09-19 | Strong Sell |
Emmanuel Papadakis Analyst Color
Get additional color on Emmanuel Papadakis's coverage of popular stocks
Emmanuel Papadakis's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Novartis AgNVS | 5 | Hold | N/A | N/A | Upgrades | 8 months ago |
SanofiSNY | 4 | Strong Buy | N/A | N/A | Upgrades | a year ago |
Biontech SeBNTX | 9 | Strong Buy | $150.00 | N/A | Maintains | 2 years ago |
Moderna IncMRNA | 7 | Hold | $80.00 | N/A | Upgrades | 2 years ago |
Astrazeneca PLCAZN | 3 | Hold | N/A | N/A | Upgrades | 2 years ago |
Grifols SaGRFS | 2 | Strong Sell | N/A | N/A | Downgrades | 3 years ago |
AlvotechALVO | 2 | Hold | $12.00 | N/A | Maintains | 4 years ago |
Novo Nordisk A SNVO | 2 | Strong Buy | N/A | N/A | Upgrades | 4 years ago |
Curevac NvCVAC | 1 | Hold | $35.00 | N/A | Initiates Coverage On | 5 years ago |
Argenx SeARGX | 1 | Hold | N/A | N/A | Initiates Coverage On | 5 years ago |
Ucb SaUCBJY | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Roche Holding LtdRHHBY | 1 | Strong Buy | N/A | N/A | Upgrades | 5 years ago |
Gsk PLCGSK | 2 | Strong Sell | N/A | N/A | Downgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.